Q4 2025 Earnings Call February 23, 2026 2:00 AM ESTCompany ParticipantsPeter Duffy - CEO & DirectorNiall McBride - CFO ...

Akari Therapeutics, Plc (Nasdaq: AKTX), an oncology biotechnology company developing antibody drug conjugates (ADCs) with novel immuno-oncology ...

Dr. Anczukow is a leading cancer biologist with expertise in RNA biology, molecular and cell biology, as well as human genetics, cancer biology, and genomics ...

Quick lube sees a growth opportunity for preventative maintenance amid a buoyant market for M&A; many suppliers ...

The USD 480 school board continued to hear High Reliability Schools (HRS updates) at its most recent meeting Monday evening, this time from Bright Start Early Learning Center (BSELC). BSELC Principal ...

ECONOMYNEXT – Revenue collected by Sri Lanka Customs in the first 19 days of February 2026 has accounted for over 96 percent ...

Sri Lanka's central bank will re-visit its inflation target as part of renewing an agreement with the government, Director of ...

Thanks, Jason, good morning and thank you for joining us on today's call to review our fourth quarter and full year 2025 results. Last July, we rolled out the Indivior Action Agenda to maximize the ...

Genus (LON:GNS) reported a strong first-half performance for FY 2026, delivering record first-half profit as growth in its ...

When Range Rover came to America in 1987, it offered something different: an SUV that was genuinely comfortable and capable, ...

Actual SEO Media, Inc. outlines how AI agents are helping teams handle routine SEO tasks faster and with less manual ...